Fulvestrant 63323-0715-05
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Human Prescription Drug
- Marketing Start
- May 20, 2019
- Listing Expires
- December 31, 2026
- Application
- NDA210326
Need to source Fulvestrant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fulvestrant | 50 mg/mL |
Drug Class
Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonists [MoA]
Selected Package
63323-0715-05Selected2 SYRINGE, GLASS in 1 CARTON (63323-715-05) / 5 mL in 1 SYRINGE, GLASS (63323-715-01)